Neurodermatitis Atopic

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-05-03
Clinical Trial Update: Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis [Phase 2]
Phase 2 trial investigating the efficacy of secukinumab in moderate to severe atopic dermatitis has completed.